IRIS PubliCatt

De Stefano, Valerio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.563
EU - Europa 5.251
AS - Asia 1.756
SA - Sud America 44
AF - Africa 39
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 7
Totale 12.679
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.495
DE - Germania 1.322
SE - Svezia 1.106
IT - Italia 846
CN - Cina 752
SG - Singapore 530
UA - Ucraina 475
IE - Irlanda 356
FR - Francia 272
ID - Indonesia 218
GB - Regno Unito 203
PL - Polonia 203
RU - Federazione Russa 149
FI - Finlandia 136
IN - India 111
CA - Canada 45
BE - Belgio 35
TR - Turchia 32
JP - Giappone 29
CI - Costa d'Avorio 27
ES - Italia 26
NL - Olanda 22
MX - Messico 21
AR - Argentina 20
AT - Austria 19
HK - Hong Kong 19
IR - Iran 19
AU - Australia 18
CZ - Repubblica Ceca 17
BR - Brasile 15
RO - Romania 13
CH - Svizzera 12
VN - Vietnam 11
CL - Cile 6
KR - Corea 6
A2 - ???statistics.table.value.countryCode.A2??? 5
IL - Israele 5
LT - Lituania 5
NO - Norvegia 5
HR - Croazia 4
HU - Ungheria 4
IQ - Iraq 4
MD - Moldavia 4
PT - Portogallo 4
BD - Bangladesh 3
DZ - Algeria 3
EE - Estonia 3
MY - Malesia 3
NG - Nigeria 3
TH - Thailandia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
DK - Danimarca 2
EU - Europa 2
GR - Grecia 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
TN - Tunisia 2
ZA - Sudafrica 2
BG - Bulgaria 1
EC - Ecuador 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LV - Lettonia 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
Totale 12.679
Salva come PNG Salva come JPEG
Città #
Chandler 1.178
Ashburn 451
Singapore 409
Dublin 350
San Mateo 277
Jacksonville 276
Jakarta 217
Wilmington 211
Nanjing 187
Warsaw 178
Ann Arbor 161
Cattolica 160
Fairfield 147
Boston 143
Dearborn 143
Milan 134
Rome 124
New York 121
Woodbridge 121
Houston 108
Moscow 102
Princeton 101
Redmond 95
Marseille 92
Beijing 90
Lawrence 90
Seattle 82
Los Angeles 75
Redwood City 75
Munich 73
Nanchang 68
Nürnberg 49
Chicago 47
Bremen 44
Boardman 38
Norwalk 37
Hebei 35
Kunming 33
Mountain View 33
Brussels 31
Cambridge 31
University Park 30
Hangzhou 28
Abidjan 27
Shenyang 27
Zhengzhou 27
Detroit 26
Pune 26
Florence 25
Lancaster 25
Leawood 25
Helsinki 24
Izmir 24
Jiaxing 24
Kraków 23
Tianjin 23
Changsha 21
London 21
Washington 19
Hong Kong 18
Toronto 18
Casalecchio di Reno 17
Federal 16
Mexico 16
Paris 16
Tobarra 16
Wayne 16
Brno 15
Guangzhou 14
San Diego 12
Andover 11
Falls Church 11
Hefei 11
Shanghai 11
Vienna 11
San Francisco 10
Clearwater 9
Lanzhou 9
Pordenone 9
São Paulo 9
Augusta 8
Busto Arsizio 8
Frankfurt am Main 8
Jinan 8
Phoenix 8
Santa Clara 8
Simi Valley 8
Monmouth Junction 7
Bologna 6
Edinburgh 6
Fremont 6
Naples 6
Padova 6
Perugia 6
Reston 6
Tokyo 6
Ypsilanti 6
Amsterdam 5
Atlanta 5
Changchun 5
Totale 7.269
Salva come PNG Salva come JPEG
Nome #
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 285
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 267
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients. 260
Association of congenital protein C deficiency and latent myeloproliferative disease as cause of splanchnic venous thrombosis in a 34-year-old woman 230
Haemostatic alterations induced by treatment with asparaginases and clinical consequences 192
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 171
Risk factor and etiology analysis of ischemic stroke in young adult patients 142
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 133
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 133
Safety of granulocyte-colony-stimulating factor in acute myocardial infarction (the Rigenera study). 128
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 128
Health Technology Assessment of genetic testing for susceptibility to Venous Thromboembolism in Italy 124
A Case of Heparin Allergy With Good Tolerability to Fondaparinux During Pregnancy 121
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 121
Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect 120
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 119
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 115
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms 110
Bisphosphonate therapy in multiple myeloma in preventing vertebral collapses: preliminary report 109
Fondaparinux in pregnancy: Could it be a safe option? A review of the literature. 109
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 108
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 108
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 108
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments 107
Factor V deficiency in pregnancy complicated by Rh immunization and placenta previa. A case report and review of the literature 106
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 105
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 103
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 103
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 101
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 98
Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB-TrIP study 98
A Case of Heparin Allergy With Good Tolerability to Fondaparinux During Pregnancy. 97
A real-time integrated framework to support clinical decision making for covid-19 patients 97
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms 96
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis 96
Venous thromboembolism in multiple myeloma 94
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease 93
JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis 92
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 92
Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation 92
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 91
The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia 90
Prognostic Factors Associated With Progression of Smoldering Multiple Myeloma to Symptomatic Form 88
A STARD-compliant prediction model for diagnosing thrombotic microangiopathies 88
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 88
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 86
Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis) 86
Postpartum hemorrhage 84
Autoimmune hemolytic anemia with gel-based immunohematology tests: neural network analysis 84
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 84
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 79
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 79
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 78
Inherited thrombophilia: treatment during pregnancy. 77
Factor V deficiency in pregnancy complicated by Rh immunization and placenta previa. A case report and review of the literature 77
Ineherited Thrombophilia: treatment during pregnancy 76
Improved Detection of Minimal Residual Disease by 11C-Methionine PET/CT in a Young Patient With Unusual Extramedullary Presentation of Recurrent Multiple Myeloma 75
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with Vitamin K antagonists 74
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia 71
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 71
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 70
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 69
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 68
IgD multiple myeloma a descriptive report of 17 cases: survival and response to therapy 67
Myeloid sarcoma with megakaryoblastic differentiation mimicking a sellar tumor 67
Improved Detection of Minimal Residual Disease by 11C-Methionine PET/CT in a Young Patient with Unusual Extramedullary Presentation of Recurrent Multiple Myeloma 67
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study 67
In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband 66
Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups 66
The Effects of Granulocyte Colony-Stimulating Factor in Patients with a Large Anterior Wall Acute Myocardial Infarction to Prevent Left Ventricular Remodeling: A 10-Year Follow-Up of the RIGENERA Study 66
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 66
Obstetric complications and pregnancy-related venous thromboembolism: The effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation 65
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 65
The interaction between small intestinal bacterial overgrowth and warfarin treatment 64
Evaluation of the prevalence of severe hyperhomocysteinemia in adult patients with thrombosis who underwent screening for thrombophilia 64
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net study 64
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 64
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN 63
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 63
Primary plasma cell leukemia: a retrospective multicenter study of 73 patients 62
Platelet indices and glucose control in type 1 and type 2 diabetes mellitus: A case-control study 62
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 59
Pre-Exposure to Defibrotide Prevents Endothelial Cell Activation by Lipopolysaccharide: An Ingenuity Pathway Analysis 58
Abdominal thromboses of splanchnic, renal and ovarian veins 57
Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysis 57
Associations of antiphospholipid antibodies with splanchnic vein thrombosis: a systematic review with meta-analysis 57
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 57
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 57
Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers 57
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia 56
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 56
Management of elderly patients with immune thrombocytopenia: Real-world evidence from 451 patients older than 60 years 56
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 56
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 56
Italian daily platelet transfusion practice for haematological patients undergoing high dose chemotherapy with or without stem cell transplantation: A survey by the GIMEMA Haemostasis and Thrombosis Working Party 55
Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax 55
Ultrasound-Doppler diagnosis of Budd-Chiari syndrome 54
Management of venous thromboembolism in myeloproliferative neoplasms 54
Structural analysis of protein Z gene variants in patients with foetal losses 53
Splanchnic vein thrombosis in myeloproliferative neoplasms: Risk factors for recurrences in a cohort of 181 patients 53
Totale 9.175
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.210
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.210
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020943 0 0 0 0 99 161 115 36 89 81 223 139
2020/20211.241 56 135 32 132 156 75 137 29 145 47 271 26
2021/20221.682 130 103 29 76 101 29 24 260 82 108 321 419
2022/20233.394 513 479 295 490 206 381 179 229 371 91 110 50
2023/20241.753 74 510 57 78 78 236 108 96 32 61 188 235
2024/2025925 99 135 276 123 292 0 0 0 0 0 0 0
Totale 12.960